Pay in 4 interest-free payments of $2.50 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
PatSnap's Life Sciences & Drug Discovery Intelligence (Synapse) remains a Star in the BCG matrix
but 62% shift to consumption pricing
Companies integrating CRM saw a 20% increase in upgrades in 2024
Key Assets for Success in 2024
crucial for securing contracts and funding
ALSTOM SWOT ANALYSIS TEMPLATE RESEARCH B_97 PatSnap's Life Sciences & DrugDive Deeper Into the Company's Strategic Blueprint Alstom stands at the intersection of rail modernization and decarbonization, boasting strong global contracts and tech expertise, but faces margin pressure from supply chain complexity and intense competition; regulatory shifts and EV urban mobility trends create both risk and expansion paths. Want the full story behind these strengths, risks, and growth drivers? Purchase the complete SWOT analysis to
US$ 11.15
US$ 104.59
US$ 86.55
